Your browser doesn't support javascript.
loading
Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients.
Mai, Elias K; Hielscher, Thomas; Bertsch, Uta; Salwender, Hans J; Zweegman, Sonja; Raab, Marc S; Munder, Markus; Pantani, Lucia; Mancuso, Katia; Brossart, Peter; Beksac, Meral; Blau, Igor W; Dürig, Jan; Besemer, Britta; Fenk, Roland; Reimer, Peter; van der Holt, Bronno; Hänel, Mathias; von Metzler, Ivana; Graeven, Ullrich; Müller-Tidow, Carsten; Boccadoro, Mario; Scheid, Christof; Dimopoulos, Meletios A; Hillengass, Jens; Weisel, Katja C; Cavo, Michele; Sonneveld, Pieter; Goldschmidt, Hartmut.
Afiliación
  • Mai EK; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany. elias.mai@med.uni-heidelberg.de.
  • Hielscher T; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Bertsch U; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Salwender HJ; National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.
  • Zweegman S; Tumorzentrum Asklepios Hamburg, AK Altona and AK St. Georg, Hamburg, Germany.
  • Raab MS; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands.
  • Munder M; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Pantani L; Department of Internal Medicine III, University Medical Center Mainz, Mainz, Germany.
  • Mancuso K; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Azienda Ospedaliero-Universitaria di Bologna, Università di Bologna, Bologna, Italy.
  • Brossart P; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Azienda Ospedaliero-Universitaria di Bologna, Università di Bologna, Bologna, Italy.
  • Beksac M; Department of Internal Medicine III, University Hospital Bonn, Bonn, Germany.
  • Blau IW; Department of Hematology, Ankara University School of Medicine, Ankara, Turkey.
  • Dürig J; Medical Clinic, Charité University Medicine Berlin, Berlin, Germany.
  • Besemer B; Department of Hematology, University Clinic Essen, Essen, Germany.
  • Fenk R; Department of Hematology, Oncology and Immunology, University Hospital Tübingen, Tübingen, Germany.
  • Reimer P; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany.
  • van der Holt B; Klinik für Hämatologie, Evangelische Kliniken Essen Mitte, Evangelisches Krankenhaus Essen-Werden, Essen, Germany.
  • Hänel M; HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.
  • von Metzler I; Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany.
  • Graeven U; Medical Clinic II, University Hospital Frankfurt am Main, Frankfurt am Main, Germany.
  • Müller-Tidow C; Department of Internal Medicine I, Hospital Maria Hilf GmbH, Mönchengladbach, Germany.
  • Boccadoro M; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Scheid C; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.
  • Dimopoulos MA; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany.
  • Hillengass J; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Weisel KC; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Cavo M; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Sonneveld P; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Azienda Ospedaliero-Universitaria di Bologna, Università di Bologna, Bologna, Italy.
  • Goldschmidt H; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.
Leukemia ; 38(3): 640-647, 2024 Mar.
Article en En | MEDLINE | ID: mdl-38062124
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Límite: Humans / Middle aged Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Límite: Humans / Middle aged Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Alemania